When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PBYI - Puma Biotech announces new data on strategies to improve tolerability of neratinib
Puma Biotechnology Inc
Puma Biotechnology (NASDAQ:PBYI) reports positive preliminary results from an open-label Phase 2 clinical trial, CONTROL, evaluating certain approaches to mitigating diarrheal toxicity associated with breast cancer med neratinib, the most common treatment-related adverse event. The data were just published in September issue of Annals of Oncology.
More news on: Puma Biotechnology, Inc., Healthcare stocks news, Stocks on the move,